Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certican in HLA-identical Kidney Transplant
NCT01653041Phase 4Completed
- Sponsor
- Hospital do Rim e Hipertensão
- Start
- Aug 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, sponsored by Hospital do Rim e Hipertensão. Started Aug 2012; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01653041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653041.